Wang, Y.; Zhu, M.; Yuan, B.; Zhang, K.; Zhong, M.; Yi, W.; Xu, X.; Duan, X.
VSP-17, a New PPARγ Agonist, Suppresses the Metastasis of Triple-Negative Breast Cancer via Upregulating the Expression of E-Cadherin. Molecules 2018, 23, 121.
https://doi.org/10.3390/molecules23010121
AMA Style
Wang Y, Zhu M, Yuan B, Zhang K, Zhong M, Yi W, Xu X, Duan X.
VSP-17, a New PPARγ Agonist, Suppresses the Metastasis of Triple-Negative Breast Cancer via Upregulating the Expression of E-Cadherin. Molecules. 2018; 23(1):121.
https://doi.org/10.3390/molecules23010121
Chicago/Turabian Style
Wang, Yuhui, Menglin Zhu, Bo Yuan, Kefeng Zhang, Mingli Zhong, Wei Yi, Xiaotian Xu, and Xiaoqun Duan.
2018. "VSP-17, a New PPARγ Agonist, Suppresses the Metastasis of Triple-Negative Breast Cancer via Upregulating the Expression of E-Cadherin" Molecules 23, no. 1: 121.
https://doi.org/10.3390/molecules23010121
APA Style
Wang, Y., Zhu, M., Yuan, B., Zhang, K., Zhong, M., Yi, W., Xu, X., & Duan, X.
(2018). VSP-17, a New PPARγ Agonist, Suppresses the Metastasis of Triple-Negative Breast Cancer via Upregulating the Expression of E-Cadherin. Molecules, 23(1), 121.
https://doi.org/10.3390/molecules23010121